Literature DB >> 26991889

Baseline medical comorbidities in adults randomized in the STRIDE trial for psychostimulant use disorders.

Adriane M Dela Cruz1, Thomas Carmody1, Tracy L Greer1, Chad D Rethorst1, Diane Warden1, Robrina Walker1, Madhukar H Trivedi1.   

Abstract

BACKGROUND AND OBJECTIVES: Rates of medical illnesses may be higher among individuals with substance use disorders, complicating their care. This study aimed to expand the understanding of other medical conditions in treatment-seeking adults with stimulant use disorder (SUD) using data from Stimulant Reduction Intervention using Dose Exercise (STRIDE), a randomized, multisite trial investigating exercise augmentation of treatment as usual.
METHODS: Utilizing STRIDE baseline data, we examined demographic and clinical characteristics based on the number of self-reported diagnosed medical conditions among participants meeting eligibility criteria (passing medical screening exam and maximal exercise test, non-opioid dependent, no concomitant beta blocker, or opioid replacement therapy).
RESULTS: The majority (59%) of study participants (N = 302, mean age all participants = 39 years) did not report any history of other medical problems. Those with two or more conditions were older (mean age 46 years), reported more pain and worse physical functioning, and more psychiatric disorders (average 1.44). Hypertension was more common among participants with cocaine use disorders only (present in 16%) and liver disease was more common in those with cocaine plus other stimulant use disorders (present in 7%). CONCLUSION AND SCIENTIFIC SIGNIFICANCE: In this sample, patients with SUD were in surprisingly good health. A subpopulation had an overall higher burden of illness with worsened physical and psychiatric functioning. Provision of coordinated care may optimize treatment outcomes for patients based on medical comorbidity burden as well as type of drug abused, although these conclusions should be considered preliminary as they are based on self-reported data.
© 2016 American Academy of Addiction Psychiatry.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26991889      PMCID: PMC4818002          DOI: 10.1111/ajad.12363

Source DB:  PubMed          Journal:  Am J Addict        ISSN: 1055-0496


  26 in total

1.  The Self-Administered Comorbidity Questionnaire: a new method to assess comorbidity for clinical and health services research.

Authors:  Oliver Sangha; Gerold Stucki; Matthew H Liang; Anne H Fossel; Jeffrey N Katz
Journal:  Arthritis Rheum       Date:  2003-04-15

2.  Longitudinal changes in drug use severity and physical health-related quality of life among untreated stimulant users.

Authors:  Tyrone F Borders; Brenda M Booth; Russel S Falck; Carl Leukefeld; Jichuan Wang; Robert G Carlson
Journal:  Addict Behav       Date:  2009-06-06       Impact factor: 3.913

3.  The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection.

Authors:  J E Ware; C D Sherbourne
Journal:  Med Care       Date:  1992-06       Impact factor: 2.983

4.  A scale for the assessment of hedonic tone the Snaith-Hamilton Pleasure Scale.

Authors:  R P Snaith; M Hamilton; S Morley; A Humayan; D Hargreaves; P Trigwell
Journal:  Br J Psychiatry       Date:  1995-07       Impact factor: 9.319

5.  Longitudinal application of the medical outcomes study 36-item short-form health survey with not-in-treatment crack-cocaine users.

Authors:  R S Falck; J Wang; H A Siegal; R G Carlson
Journal:  Med Care       Date:  2000-09       Impact factor: 2.983

6.  Quality of Life Enjoyment and Satisfaction Questionnaire: a new measure.

Authors:  J Endicott; J Nee; W Harrison; R Blumenthal
Journal:  Psychopharmacol Bull       Date:  1993

7.  The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression.

Authors:  A John Rush; Madhukar H Trivedi; Hicham M Ibrahim; Thomas J Carmody; Bruce Arnow; Daniel N Klein; John C Markowitz; Philip T Ninan; Susan Kornstein; Rachel Manber; Michael E Thase; James H Kocsis; Martin B Keller
Journal:  Biol Psychiatry       Date:  2003-09-01       Impact factor: 13.382

8.  An improved diagnostic evaluation instrument for substance abuse patients. The Addiction Severity Index.

Authors:  A T McLellan; L Luborsky; G E Woody; C P O'Brien
Journal:  J Nerv Ment Dis       Date:  1980-01       Impact factor: 2.254

9.  Medical and psychiatric conditions of alcohol and drug treatment patients in an HMO: comparison with matched controls.

Authors:  Jennifer R Mertens; Yun W Lu; Sujaya Parthasarathy; Charles Moore; Constance M Weisner
Journal:  Arch Intern Med       Date:  2003-11-10

10.  Current physical health problems and their predictors among a community sample of crack-cocaine smokers in Ohio.

Authors:  Russel S Falck; Jichuan Wang; Harvey A Siegal; Robert G Carlson
Journal:  J Psychoactive Drugs       Date:  2003 Oct-Dec
View more
  1 in total

1.  Cardiorespiratory fitness and body composition of stimulant users: A baseline analysis of the STRIDE cohort.

Authors:  Mark Stoutenberg; Chad D Rethorst; Denise C Vidot; Tracy L Greer; Madhukar H Trivedi
Journal:  J Subst Abuse Treat       Date:  2017-05-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.